Replies to post #25066 on Revive Therapeutics Ltd (RVVTF)

[hotmeat]

Better they take the time of collect comprehensive, and most importantly, reliable data rather than trying to pull a "fast one" on the FDA like another company did, to it's detriment, and great cost to shareholders.